Maximino Redondo | Health Professions | Best Scholar Award

Posted on by Academic Excellence

Prof. Dr. Maximino Redondo | Health Professions | Best Scholar Award

Prof. Dr. Maximino Redondo, Universidad de Málaga, Spain

Dr. Maximino Redondo Bautista is an accomplished Spanish physician and professor, with an extensive career in clinical laboratory medicine and health research. Since 1993, he has served as a Medical Specialist at Hospital Universitario Costa del Sol in Málaga, while concurrently advancing academia as a full-time professor at the University of Málaga. With six recognized research sexennia and leadership of the hospital’s Research Unit, Dr. Redondo has made significant strides in translational medicine, oncology, and chronic disease studies. He has led 18 competitive research projects supported by the Instituto de Salud Carlos III and regional health bodies. His international collaborations and contributions to multicenter studies have shaped evidence-based healthcare practices in Spain. Through consistent involvement in national research networks like REDISSEC and RICAPPS, he promotes innovation, training, and the implementation of real-world healthcare solutions.

Profile

Google Scholar

🌟 Assessment of Suitability for the Research for Best Scholar Award: Dr. Maximino Redondo Bautista

Summary of Suitability:

Dr. Maximino Redondo Bautista stands as a highly qualified candidate for the Research for Best Scholar Award, bringing decades of academic, clinical, and research excellence to the forefront. With a strong dual appointment as a Medical Specialist at the Hospital Universitario Costa del Sol since 1993 and a Full Professor (Catedrático) at the University of Málaga since 2023, his contributions straddle both advanced medical practice and academic leadership.

Dr. Redondo earned his Doctorate in Medicine and Surgery from the University of Granada in 1991, along with specialized academic training in Epidemiology and Clinical Research. His professional journey reflects a consistent climb, with long-term involvement in academia and research, having held multiple professorial roles and received continuous competitive research funding. Over the years, he has served as Principal Investigator in 18 competitive research projects funded by the Instituto de Salud Carlos III and the Andalusian Health Council.

🎓 Education

Dr. Redondo holds a Doctorate in Medicine and Surgery from the University of Granada (1991), which laid the groundwork for his specialization in clinical analysis and translational medical research. He also earned a University Expert Degree in Epidemiology and Clinical Research from the same university in 2000. His academic journey began with a residency (MIR) in Clinical Analysis at the University Hospital Virgen de las Nieves (1986–1990), followed by key professional training in top Spanish medical centers. Over the years, he has cultivated a strong background in biomedical sciences and public health, supported by further academic certification and participation in national programs. His extensive formal education, complemented by teaching roles since 1992, has empowered him to nurture emerging scientists, shape academic curricula, and contribute to policy-oriented research in health sciences.

💼 Professional Experience

Dr. Maximino Redondo has more than three decades of experience in clinical medicine, research, and higher education. Since 1993, he has worked as a Clinical Laboratory Specialist at Hospital Universitario Costa del Sol. In academia, he has been a professor at the University of Málaga since 1992, most recently serving as Chair Professor in the Department of Surgical Specialties, Biochemistry, and Immunology. He also served as a Tenured Professor and Associate Professor over the years. His extensive career includes significant research leadership: serving on competitive programs at Instituto de Salud Carlos III and the Andalusian Health Council. He coordinates national research networks, leads clinical studies, and contributes to translational research initiatives. Dr. Redondo’s integrated professional approach bridges patient care, scientific inquiry, and academic excellence, shaping policy and fostering innovation in health service delivery.

🏅 Awards and Recognition 

Dr. Redondo has been widely recognized for his exceptional contributions to biomedical research, health policy, and academic mentorship. His work has earned six officially recognized sexenios de investigación (six-year research productivity periods), a distinguished mark in Spanish academia. He has led 18 competitive research projects and was repeatedly selected for national Intensification Programs by both Instituto de Salud Carlos III and the Andalusian Ministry of Health. Dr. Redondo played a central role in the REDISSEC and RICAPPS research networks, coordinating multicenter studies and leading national healthcare strategies. His efforts have translated research findings into impactful healthcare practices and evidence-based policy reforms. As a principal investigator and mentor, he has contributed to researcher training programs and advanced Spain’s health system through innovation and collaborative research. His influence spans medical education, diagnostics, and national public health frameworks.

🌍 Research Skills On Health Professions

Dr. Redondo excels in translational research, clinical epidemiology, biostatistics, and health services evaluation. His primary focus lies in oncology, chronic illness management, and the integration of research findings into real-world clinical practice. His skillset includes designing multicenter studies, applying evidence-based medicine, and leveraging laboratory diagnostics to inform health policies. As a senior researcher and group leader in the RICAPPS (RD21/0016/0015 and RD24/0005/0016) and REDISSEC networks, he coordinates collaborative research among hospitals, universities, and institutes across Spain. He also mentors early-career researchers, promotes interdisciplinary partnerships, and strengthens knowledge translation in healthcare. His ability to secure competitive funding and lead innovative health projects demonstrates scientific and managerial expertise. Dr. Redondo also contributes to editorial, evaluation, and strategic committees, ensuring the long-term sustainability and impact of research initiatives aimed at improving public health outcomes.

📖 Publication Top Notes

  • 🔬 Overexpression of clusterin in human breast carcinoma
    Authors: M. Redondo, E. Villar, J. Torres-Muñoz, T. Tellez, M. Morell, C.K. Petito
    Citation: The American Journal of Pathology, 157(2), 393–399.
    Year: 2000

  • 🧪 Immunotherapy: a challenge of breast cancer treatment
    Authors: M. García-Aranda, M. Redondo
    Citation: Cancers, 11(12), 1822.
    Year: 2019

  • 🧫 Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia
    Authors: C. Marchal, M. Redondo, M. Padilla, J. Caballero, I. Rodrigo, J. Garcia, et al.
    Citation: Histology and Histopathology, 2004.
    Year: 2004

  • 🧠 Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus
    Authors: E. Matas-Rico, B. Garcia-Diaz, P. Llebrez-Zayas, D. López-Barroso, L. Santin, M. Redondo, et al.
    Citation: Molecular and Cellular Neuroscience, 39(3), 342–355.
    Year: 2008

  • 💉 Bcl-2 inhibition to overcome resistance to chemo- and immunotherapy
    Authors: M. García-Aranda, E. Pérez-Ruiz, M. Redondo
    Citation: International Journal of Molecular Sciences, 19(12), 3950.
    Year: 2018

  • 🧬 Presence of HPV 16 sequences in laryngeal carcinomas
    Authors: M. Perez-Ayala, F. Ruiz-Cabello, F. Esteban, A. Concha, M. Redondo, et al.
    Citation: International Journal of Cancer, 46(1), 8–11.
    Year: 1990

  • 🧻 The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs
    Authors: M. Muñoz, R. Coveñas, F. Esteban, M. Redondo
    Citation: Journal of Biosciences, 40, 441–463.
    Year: 2015

  • 🫁 Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters
    Authors: M. Redondo, A. Concha, R. Oldiviela, A. Cueto, A. Gonzalez, F. Garrido, et al.
    Citation: Cancer Research, 51(18), 4948–4954.
    Year: 1991

  • 🔬 NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2
    Authors: M. Muñoz, M. Rosso, F.J. Aguilar, M.A. González-Moles, M. Redondo, et al.
    Citation: Investigational New Drugs, 26, 111–118.
    Year: 2008

  • 🎯 Protein kinase targets in breast cancer
    Authors: M. García-Aranda, M. Redondo
    Citation: International Journal of Molecular Sciences, 18(12), 2543.
    Year: 2017

Wentao Han | Medicine | Best Researcher Award

Posted on by Academic Excellence

Dr. Wentao Han | Medicine | Best Researcher Award

Dr. Wentao Han, Department of Ophthalmology, The Second Xiangya Hospital, Central South University, China

Wentao Han is a dedicated ophthalmology researcher specializing in diabetic eye complications, dry eye syndrome, and gene therapy. Currently pursuing his research at the Second Xiangya Hospital of Central South University, China, he has demonstrated a strong passion for advancing medical science through innovative studies. His contributions to ocular disease research, particularly in understanding the gut-eye axis and corneal wound healing, highlight his interdisciplinary approach. He has authored multiple high-impact journal articles and actively collaborates with global scholars. His research on machine learning applications in medical diagnosis showcases his forward-thinking vision in integrating AI with healthcare. Beyond academia, Wentao Han serves as a reviewer for prestigious journals, contributing to the integrity of scientific publications. His dedication to translational medicine and biomarker identification continues to shape new therapeutic strategies. His work aims to bridge laboratory findings with clinical applications, improving patient outcomes in ophthalmology and metabolic diseases.

Professional Profile 

Orcid

Suitability for the Research for Best Researcher Award – Wentao Han

Wentao Han demonstrates a strong research background in ophthalmology, particularly in the areas of diabetic eye complications, dry eye syndrome, and corneal wound healing. Currently pursuing research at the Second Xiangya Hospital of Central South University, he has made notable contributions to the field, with multiple high-impact publications in reputable journals. His expertise in the “gut metabolites–inflammation–eye axis” and gene therapy for Meibomian Gland Dysfunction (MGD) highlights his innovative approach to addressing critical challenges in ophthalmology.

His publication record is impressive, with multiple papers in Q1 and Q2 journals, including Pharmaceutics, The Ocular Surface, Acta Diabetologica, and Journal of Medical Internet Research. Notably, his work on machine learning prediction models, autophagy in retinal precursor cells, and the gut-eye axis showcases a multidisciplinary research approach. His role as an invited reviewer for respected journals further establishes his credibility in the academic community.

🎓 Education 

Wentao Han is currently pursuing advanced medical research at Central South University, Changsha, China, within the Department of Ophthalmology at the Second Xiangya Hospital. His academic journey reflects a deep commitment to ophthalmic research, focusing on diabetic retinopathy, ocular surface disorders, and corneal healing mechanisms. Through rigorous training and hands-on experience in clinical settings, he has honed his expertise in evidence-based medicine and translational research. His coursework and mentorship under leading ophthalmologists have allowed him to integrate molecular biology with patient-centered investigations. Additionally, he actively participates in research seminars, workshops, and scientific collaborations, reinforcing his knowledge of bioinformatics, gene therapy, and regenerative medicine. His strong foundation in medical sciences, combined with a keen interest in technological advancements, positions him as a promising young researcher in ophthalmology. His education has equipped him with critical skills to contribute to groundbreaking discoveries in the field of ocular diseases.

💼 Professional Experience 

As a researcher in ophthalmology at the Second Xiangya Hospital of Central South University, Wentao Han has contributed significantly to understanding diabetic eye complications and ocular disease mechanisms. His professional experience includes conducting clinical and preclinical studies on dry eye syndrome, corneal wound healing, and the gut-eye axis. He has extensive expertise in meta-analyses, molecular diagnostics, and the application of artificial intelligence in disease prediction. His work in identifying novel biomarkers for diabetic retinopathy has been widely recognized. Additionally, he collaborates with interdisciplinary teams, integrating bioinformatics and evidence-based medicine to develop innovative treatment approaches. Han’s active involvement in academic publishing and peer review for high-impact journals reflects his commitment to advancing medical knowledge. His current projects involve investigating gene therapy for meibomian gland dysfunction and corneal regeneration, with the aim of translating scientific discoveries into clinical applications that enhance patient care in ophthalmology.

🏅 Awards and Recognition 

Wentao Han has received multiple recognitions for his outstanding contributions to ophthalmic research. He has been an invited reviewer for prestigious journals such as Cell Death Discovery (IF = 7) and Acta Diabetologia (IF = 3.9), underscoring his expertise in diabetes-related ocular disorders. His research on gut metabolites’ role in eye diseases has been acknowledged at international conferences. Several of his published articles in Q1 journals have earned high citations, reflecting their impact on the scientific community. Han has also contributed to the development of machine learning prediction models for gestational diabetes mellitus, further showcasing his interdisciplinary proficiency. His involvement in groundbreaking studies on corneal wound healing has positioned him as a promising young researcher in ophthalmology. With a strong publication record, peer recognition, and contributions to medical advancements, Han continues to be a driving force in translational ophthalmic research and clinical innovation.

🌍 Research Skills On Medicine

Wentao Han possesses a diverse set of research skills that bridge molecular biology, clinical medicine, and artificial intelligence applications in ophthalmology. His expertise includes conducting systematic reviews, meta-analyses, and experimental research on diabetic retinopathy and dry eye syndrome. He is proficient in bioinformatics tools for gene analysis and biomarker identification, which he applies to precision medicine. Han is skilled in laboratory techniques such as immunohistochemistry, cell culture, and animal models for ocular disease studies. His ability to integrate AI and machine learning into medical research has led to innovative predictive models for disease diagnosis. Additionally, his work in gene therapy for corneal and meibomian gland dysfunction highlights his translational research capabilities. Han’s interdisciplinary approach allows him to explore novel therapeutic targets, making significant contributions to evidence-based medicine. His research aims to improve diagnostic accuracy and therapeutic interventions in ophthalmic and metabolic disorders.

📖 Publication Top Notes

  • Research Progress and Potential Applications of Spermidine in Ocular Diseases
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Journal of Medical Internet Research, 2022-03-16
    • Year: 2022
    • DOI: 10.2196/26634
  • Genome Analysis and Identification of Key Pathway in Visceral Adipose Tissue from Obesity-Related Diabetes
    • Authors: Wentao Han
    • Citation: Proceedings of the 2021 International Conference on Bioinformatics and Intelligent Computing, 2021-01-22
    • Year: 2021
    • DOI: 10.1145/3448748.3448757
  • Machine Learning Prediction Models for Gestational Diabetes Mellitus: Meta-analysis (Preprint)
    • Authors: Zheqing Zhang, Luqian Yang, Wentao Han, Yaoyu Wu, Linhui Zhang, Chun Gao, Kui Jiang, Yun Liu, Huiqun Wu
    • Citation: Preprint, 2020-12-19
    • Year: 2020
    • DOI: 10.2196/preprints.26634
  • Construction of a Knowledge Graph for Diabetes Complications from Expert-Reviewed Clinical Evidences
    • Authors: Wentao Han
    • Citation: Computer Assisted Surgery (Abingdon, England), 2020-11-25
    • Year: 2020
    • DOI: 10.1080/24699322.2020.1850866
    • PMID: 33275462
  • Association Between Retinol Binding Protein 4 and Diabetic Retinopathy Among Type 2 Diabetic Patients: A Meta-analysis
    • Authors: Wentao Han, Huagen Wei, Weizheng Kong, Jing Wang, Luqian Yang, Huiqun Wu
    • Citation: Acta Diabetologica, 2020-10
    • Year: 2020
    • DOI: 10.1007/s00592-020-01535-3

 

Anna Cecilia Trolesi Reis Borges Costa | Epidemiology | Best Researcher Award

Posted on by Academic Excellence

Dr. Anna Cecilia Trolesi Reis Borges Costa | Epidemiology | Best Researcher Award

👤 Dr. Anna Cecilia Trolesi Reis Borges Costa, Federal University of Lavras, Brazil

Anna Cecília Trolesi Reis Borges Costa, born on April 5, 1991, is a Brazilian veterinarian with a strong focus on epidemiology. She earned her Ph.D. in Veterinary Sciences from Universidade Federal de Lavras (UFLA) in 2024, with research exploring bovine brucellosis surveillance and control in Minas Gerais. Anna’s career spans a range of professional experiences, including working as a small animal clinician, a volunteer teacher in epidemiology, and a visiting professor at Brazilian universities. She is recognized for her extensive research in veterinary epidemiology and public health, particularly in zoonotic diseases like leptospirosis and brucellosis. Her contributions to the field are supported by multiple grants, including the prestigious CNPq Postdoctoral Abroad Scholarship. Currently, she continues her work internationally, with a focus on advancing veterinary science and public health.

Professional Profile

Orcid

🌟 Assessment of Suitability for the “Research for Best Researcher Award”

Dr. Anna Cecília Trolesi Reis Borges Costa’s exceptional academic and professional journey demonstrates her strong eligibility for the “Research for Best Researcher Award.” Her contributions to veterinary sciences, with a focus on epidemiology, public health, and infectious disease control, align with the criteria of groundbreaking research and societal impact.

Dr. Costa has a robust academic background, completing her PhD in Veterinary Sciences at the Universidade Federal de Lavras in 2024, with international collaborations at the University of Illinois and the University of Prince Edward Island. Her thesis on risk-based bovine brucellosis surveillance and control highlights her innovative approach to addressing critical challenges in veterinary public health. Complementing this, her Master’s dissertation focused on a “One Health” approach to leptospirosis, showcasing her commitment to interdisciplinary research that integrates animal, human, and environmental health.

🎓 Education 

Anna Cecília Trolesi Reis Borges Costa’s educational journey includes a series of distinguished academic accomplishments. She holds a Ph.D. in Veterinary Sciences from Universidade Federal de Lavras (2024), where her thesis focused on “Risk-based bovine brucellosis surveillance and control.” This was pursued during a collaborative period at the University of Illinois. Anna also completed her Master’s in Veterinary Sciences at UFLA in 2020, researching “Epidemiology of leptospirosis in humans and unowned dogs,” which emphasized the One Health approach. She received several prestigious grants throughout her academic career, including from CAPES and the Canadian Government for further specialization in epidemiology at the University of Prince Edward Island in 2022. Anna completed her undergraduate degree in Veterinary Medicine at UFLA in 2014. Her academic background has laid a strong foundation for her work in epidemiology and public health.

💼   Professional Experience

Anna Cecília Trolesi Reis Borges Costa’s professional journey includes several roles in the field of veterinary science, with a particular focus on epidemiology. From 2019 to 2024, she served as a volunteer teacher in epidemiology and public health at UFLA. In 2021, she expanded her teaching experience as a visiting professor at both Universidade Federal de Alfenas and Universidade Santo Amaro in Brazil. Anna also worked as a government employee in Três Corações, Brazil, offering specialized technical services as a small animal clinician and at a local shelter. Her clinical expertise was further honed through her roles at Recanto Animal and Bicho Chic Veterinary Clinic, where she worked with small animals. Additionally, Anna has gained practical experience in large animal reproduction during her internship at UFLA’s veterinary hospital. Her multidisciplinary experience makes her an invaluable contributor to both education and clinical veterinary practice.

🏅Awards and Recognition 

Anna Cecília Trolesi Reis Borges Costa has been recognized for her outstanding academic and professional contributions to veterinary science and epidemiology. Her most notable accolade is the CNPq Postdoctoral Abroad Scholarship, which enabled her to pursue further studies in veterinary science. Additionally, she has received multiple grants, including funding from CAPES (Brazil) and the Canadian Government for her specialization in epidemiology. Anna’s research in veterinary epidemiology, particularly in zoonotic diseases, has earned her several citations in international journals. Her work in the prevention and control of bovine brucellosis and leptospirosis in public shelters has been pivotal to advancing veterinary public health. Anna’s efforts in epidemiology education, research, and fieldwork have made her a respected figure in the veterinary community, and her expertise continues to be recognized by academic institutions and scientific bodies worldwide.

🌍 Research Skills On Epidemiology

Anna Cecília Trolesi Reis Borges Costa’s research skills are rooted in her extensive training in veterinary science, epidemiology, and public health. She excels in data analysis and epidemiologic modeling, crucial for assessing and controlling zoonotic diseases. Her research expertise spans a wide range of subjects, from molecular biology and microbiology to collective health. Anna has developed robust research methodologies, including spatiotemporal analysis and network analysis, to assess disease outbreaks and health risks. Her ability to conduct comprehensive risk assessments and surveillance studies is evident in her work on bovine brucellosis and leptospirosis in Brazil. Furthermore, Anna is highly skilled in integrating One Health approaches into her research, which considers the interconnectedness of human, animal, and environmental health. Her research has led to significant publications in peer-reviewed journals, demonstrating her aptitude in advancing veterinary epidemiology and contributing valuable knowledge to the scientific community.

📖 Publication Top Notes

  • Clinical-epidemiological profile of the canine population in a shelter, Minas Gerais, Brazil, 2019-2020
    • Authors: Raisa Abreu Bragança Colocho, Anna Cecília Trolesi Reis Borges Costa, Blenda Araujo Martins Ferreira, Amanda Carvalho Rosado Ferreira, Dircéia Aparecida da Costa Custódio, Carine Rodrigues Pereira, Erika Aparecida Oliveira, Isaac David Pineda Sirias, Sérgio Novais de Melo, Ana Beatriz Barion Souza, et al.
    • Citation: Colocho, R.A.B., Costa, A.C.T.R.B., Ferreira, B.A.M., Ferreira, A.C.R., Custódio, D.A.C., Pereira, C.R., Oliveira, E.A., Sirias, I.D.P., Melo, S.N., Souza, A.B.B. (2025). Clinical-epidemiological profile of the canine population in a shelter, Minas Gerais, Brazil, 2019-2020. Journal of Applied Animal Welfare Science.
  • Resistance Training Improves the Immune Response, Mainly Associated with CD8+ T Lymphocytes and B Lymphocytes, in Mice
    • Authors: Fernanda Cristina Pedro, Marina Martins de Oliveira, Rafaella Silva Andrade, Anna Cecília Trolesi Reis Borges Costa, Carine Rodrigues Pereira, Pedro Felipe Rodrigues e Oliveira, Soraia Macari, Cândido Celso Coimbra, Elaine Maria Seles Dorneles, Luciano José Pereira
    • Citation: Pedro, F.C., de Oliveira, M.M., Andrade, R.S., Costa, A.C.T.R.B., Pereira, C.R., Rodrigues e Oliveira, P.F., Macari, S., Coimbra, C.C., Dorneles, E.M.S., Pereira, L.J. (2024). Resistance training improves the immune response, mainly associated with CD8+ T lymphocytes and B lymphocytes, in mice. Brazilian Archives of Biology and Technology.
  • Network vulnerability of cattle movement in Minas Gerais, Brazil, from 2013 to 2022
    • Authors: Anna Cecília Trolesi Reis Borges Costa, Lara Savini, Luciana Faria de Oliveira, Andrey Pereira Lage, Elaine Maria Seles Dorneles, Luca Candeloro
    • Citation: Costa, A.C.T.R.B., Savini, L., de Oliveira, L.F., Lage, A.P., Dorneles, E.M.S., Candeloro, L. (2024). Network vulnerability of cattle movement in Minas Gerais, Brazil, from 2013 to 2022.

Jing Sun | Epidemiology | Best Researcher Award

Posted on by Academic Excellence

Assoc. Prof. Dr. Jing Sun | Epidemiology | Best Researcher Award

👤 Assoc. Prof. Dr. Jing Sun, Zhejiang A&F University, China

Dr. Jing Sun, born in December 1987, is an esteemed Associate Professor in Veterinary Discipline at Zhejiang A&F University. She holds a Doctorate in Preventive Veterinary Medicine from Zhejiang University and has honed her expertise as a Visiting Scholar at The Ohio State University. Dr. Sun’s work focuses on clinical detection technologies for animal diseases, antiviral vaccine development, and epidemiological research on viral diseases. She has led numerous research projects, including those funded by prestigious national and provincial foundations. Recognized for her contributions, she has received accolades such as the National Science and Technology Invention Prize and the Gold Award in Innovation Competitions. Her pioneering research on Listeria monocytogenes and avian metapneumovirus vaccines has made significant impacts in the field. With a passion for advancing veterinary sciences, Dr. Sun continues to inspire the next generation through her teaching and groundbreaking research.

Professional Profile

Scopus

Orcid

🌟  Assessment of Suitability for the Research for Best Researcher Award: Jing Sun

Summary of Suitability
Dr. Jing Sun demonstrates a strong candidacy for the Research for Best Researcher Award, backed by her robust academic background, significant research contributions, and an impressive track record of awards and achievements. With a Doctorate in Preventive Veterinary Medicine from Zhejiang University and international exposure as a visiting scholar at The Ohio State University, Dr. Sun has cultivated a comprehensive expertise in veterinary biosciences and animal disease prevention.

Her work as an Associate Professor and earlier as a Lecturer highlights her consistent dedication to academic and research excellence. Dr. Sun’s contributions to clinical detection technologies, antiviral vaccines, and epidemiological research are evident in her leadership and participation in numerous high-impact projects funded by prestigious national and provincial organizations. She has successfully led and contributed to studies on molecular mechanisms, vaccine development, and diagnostic technologies, showcasing her innovative research approach.

🎓  Education 

Dr. Jing Sun’s educational journey showcases her commitment to veterinary medicine. She completed her Master’s and Doctorate degrees in Preventive Veterinary Medicine at Zhejiang University, excelling in her studies and research. During her doctoral studies, she gained international experience as a Visiting Scholar at The Ohio State University, specializing in Veterinary Biosciences. This exposure provided her with advanced research techniques and a global perspective on veterinary challenges. Dr. Sun’s academic focus on molecular mechanisms and vaccine development has underpinned her contributions to animal disease prevention. Her education laid a strong foundation for her career, fostering an interdisciplinary approach to solving complex veterinary problems. Her academic achievements and research excellence highlight her dedication to improving animal health through innovation and science.

💼  Professional Experience 

Dr. Jing Sun has an illustrious professional career spanning over a decade. Since January 2022, she has served as an Associate Professor at Zhejiang A&F University, where she leads initiatives in the Veterinary Discipline. From 2014 to 2021, she contributed as a Lecturer, building a reputation for innovative teaching and impactful research. Her expertise includes developing clinical detection technologies, advancing antiviral vaccines, and conducting epidemiological studies on animal viral diseases. Dr. Sun has been a key participant and leader in several high-profile research projects, including the National Key R&D Program and provincial foundation studies. Her professional contributions have earned her numerous accolades, reflecting her commitment to advancing veterinary medicine. With her dynamic blend of teaching, research, and collaboration, Dr. Sun is a cornerstone in her institution’s academic and research advancements.

🏅Awards and Recognitions 

Dr. Jing Sun’s accolades are a testament to her exceptional contributions to veterinary science. She was awarded the prestigious 1st Prize in the National Science and Technology Invention Category at the 4th China Graduate Rural Revitalization Science and Technology Competition in 2024. Additionally, she won the Gold Award at the Zhejiang A&F University Student Innovation Competition and the 2nd Prize in the Teacher Teaching Innovation Competition. Dr. Sun’s innovative projects earned her recognition in the “Campus-Enterprise Cooperation Double Hundred Plan” and the “Black Technology” Display at the Challenge Cup competitions. Her teaching prowess was acknowledged with the “New Teacher of the Year” and “New Hope Star” awards. These honors reflect her groundbreaking research, exceptional teaching, and unwavering dedication to advancing veterinary sciences.

🌍 Research Skills On Epidemiology

Dr. Jing Sun’s research expertise lies at the intersection of molecular biology and veterinary medicine. She excels in developing clinical detection technologies for animal diseases, with a focus on Listeria monocytogenes and avian metapneumovirus. Her skills include advanced molecular diagnostics, vaccine development, and epidemiological modeling of animal viral diseases. Dr. Sun has led critical research on oxidative stress mechanisms, vaccine efficacy, and immune escape mechanisms, funded by prestigious grants from national and provincial agencies. Her collaborative approach in large-scale research programs demonstrates her ability to translate scientific knowledge into practical solutions. With a strong foundation in biosciences and a commitment to innovation, Dr. Sun is a leader in her field, driving advancements in animal health and disease prevention.

📖 Publication Top Notes

  • Title: Establishment and application of a one-step multiplex real-time PCR assay for detection of A, B, and C subtypes of avian metapneumovirus
    Authors: Su, M., Cheng, J., Xu, X., Cheng, C., Sun, J.
    Journal: Poultry Science
    Year: 2025
  • Title: The MICOS Complex Subunit Mic60 is Hijacked by Intracellular Bacteria to Manipulate Mitochondrial Dynamics and Promote Bacterial Pathogenicity
    Authors: Cheng, C., Chen, M., Sun, J., Fang, W., Song, H.
    Journal: Advanced Science
    Year: 2024
  • Title: LADS: a powerful vaccine platform for cancer immunotherapy and prevention
    Authors: Sun, J., Wang, J., Jiang, X., Cheng, C., Song, H.
    Journal: BMC Biology
    Year: 2024
  • Title: Isolation and characterization of a novel S-gene mutation porcine deltacoronavirus with high pathogenicity from diarrhea piglet in Zhejiang Province, China, 2022
    Authors: Xu, X., Sun, J., Zheng, H., Song, H., Su, M.
    Journal: Microbial Pathogenesis
    Year: 2024
  • Title: The mitochondrial carboxylase PCCA interacts with Listeria monocytogenes phospholipase PlcB to modulate bacterial survival
    Authors: Wang, J., Cui, M., Liu, Y., Song, H., Cheng, C.
    Journal: Applied and Environmental Microbiology
    Year: 2024
  • Title: Roles of key amino acid residues of the virulence factor listeriolysin O in Listeria monocytogenes infection
    Authors: Feng, Y., Xu, J., Zhu, B., Xia, J., Cheng, C.
    Journal: Acta Microbiologica Sinica
    Year: 2024
  • Title: Isolation and characterization of a novel S1-gene insertion porcine epidemic diarrhea virus with low pathogenicity in newborn piglets
    Authors: Su, M., Wang, Y., Yan, J., Sun, D., Song, H.
    Journal: Virulence
    Year: 2024
  • Title: The glucoside transporter Lmo0738 contributes to virulence of Listeria monocytogenes
    Authors: Shen, Y., Wang, J., Ying, Y., Xu, J., Cheng, C.
    Journal: Acta Microbiologica Sinica
    Year: 2024
  • Title: Role of LPXTG-anchored protein Lmo0880 in Listeria monocytogenes infection
    Authors: Lin, K., Li, H., Zhao, X., Deng, S., Cheng, C.
    Journal: Acta Microbiologica Sinica
    Year: 2024
  • Title: Characterization of a DsbA family protein reveals its crucial role in oxidative stress tolerance of Listeria monocytogenes
    Authors: Xia, J., Luo, Y., Chen, M., Song, H., Cheng, C.
    Journal: Microbiology Spectrum
    Year: 2023